This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hashimoto, Y. Articles by Mori, H. Search for Related Content PubMed PubMed Citation Articles by Hashimoto, Y. Articles by Mori, H.

(American Journal of Pathology. 2003;163:101-110.)
© 2003 American Society for Investigative Pathology

Mutation (D472Y) in the Type 3 Repeat Domain of Cartilage Oligomeric Matrix Protein Affects Its Early Vesicle Trafficking in Endoplasmic Reticulum and Induces Apoptosis

Yusuke Hashimoto^*, Takami Tomiyama^*, Yoshiki Yamano and Hiroshi Mori^*

From the Department of Neuroscience,^* the Institute of Gerontology, and the Department of Orthopaedic Surgery, Osaka City University Medical School, Osaka, Japan

Cartilage oligomeric matrix protein (COMP) is a large pentameric extracellular glycoprotein found in cartilage, tendon, and synovium, and plays structural roles in cartilage as the fifth member of the thrombospondin family. Familial mutations in type 3 repeats of COMP are known to cause pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (EDM1). Although such mutations induce enlarged rough endoplasmic reticulum (rER) as a morphological change, the metabolic trafficking of mutated COMP remains unclear. In transfected COS7 cells, wild-type COMP was rapidly secreted into culture medium, while the great majority of COMP with the type 3 repeats mutation (D472Y) remained in the cells and a small portion of mutated COMP was secreted. This finding was followed up with a confocal study with an antibody specific to COMP, which demonstrated mutated COMP tightly associated with abnormally enlarged rER. Phosphorylated eIF2, an ER stress protein, was expressed as a pathological reaction in virtually all COS7 cells expressing mutated but not wild-type COMP. Moreover, COS7 cells expressing mutated COMP exhibited significantly more apoptotic reaction than those expressing wild-type COMP. Pathological accumulation of COMP in rER and apoptosis in COS7 cells that were induced by the mutation (D472Y) in COMP imply that COMP mutations play a role in the pathogenesis of PSACH.

This article has been cited by other articles:

				K. L. Posey, A. C. Veerisetty, P. Liu, H. R. Wang, B. J. Poindexter, R. Bick, J. L. Alcorn, and J. T. Hecht An Inducible Cartilage Oligomeric Matrix Protein Mouse Model Recapitulates Human Pseudoachondroplasia Phenotype Am. J. Pathol., October 1, 2009; 175(4): 1555 - 1563. [Abstract] [Full Text] [PDF]

				J. L. Alcorn, T. M. Merritt, M. C. Farach-Carson, H. H. Wang, and J. T. Hecht Ribozyme-mediated reduction of wild-type and mutant cartilage oligomeric matrix protein (COMP) mRNA and protein RNA, April 1, 2009; 15(4): 686 - 695. [Abstract] [Full Text] [PDF]

				K. Nishitsuji, T. Tomiyama, K. Ishibashi, K. Ito, R. Teraoka, M. P. Lambert, W. L. Klein, and H. Mori The E693{Delta} Mutation in Amyloid Precursor Protein Increases Intracellular Accumulation of Amyloid {beta} Oligomers and Causes Endoplasmic Reticulum Stress-Induced Apoptosis in Cultured Cells Am. J. Pathol., March 1, 2009; 174(3): 957 - 969. [Abstract] [Full Text] [PDF]

				G. Yang, Q. Sun, Y. Teng, F. Li, T. Weng, and X. Yang PTEN deficiency causes dyschondroplasia in mice by enhanced hypoxia-inducible factor 1{alpha} signaling and endoplasmic reticulum stress Development, November 1, 2008; 135(21): 3587 - 3597. [Abstract] [Full Text] [PDF]

				C. B. Carlson, K. A. Gunderson, and D. F. Mosher Mutations Targeting Intermodular Interfaces or Calcium Binding Destabilize the Thrombospondin-2 Signature Domain J. Biol. Chem., October 3, 2008; 283(40): 27089 - 27099. [Abstract] [Full Text] [PDF]

				V. Gagarina, A. L. Carlberg, L. Pereira-Mouries, and D. J. Hall Cartilage Oligomeric Matrix Protein Protects Cells against Death by Elevating Members of the IAP Family of Survival Proteins J. Biol. Chem., January 4, 2008; 283(1): 648 - 659. [Abstract] [Full Text] [PDF]

				M. Schmitz, A. Becker, A. Schmitz, C. Weirich, M. Paulsson, F. Zaucke, and R. Dinser Disruption of Extracellular Matrix Structure May Cause Pseudoachondroplasia Phenotypes in the Absence of Impaired Cartilage Oligomeric Matrix Protein Secretion J. Biol. Chem., October 27, 2006; 281(43): 32587 - 32595. [Abstract] [Full Text] [PDF]

				P. Holden, D. R. Keene, G. P. Lunstrum, H. P. Bachinger, and W. A. Horton Secretion of Cartilage Oligomeric Matrix Protein Is Affected by the Signal Peptide J. Biol. Chem., April 29, 2005; 280(17): 17172 - 17179. [Abstract] [Full Text] [PDF]

				R. Wilson, S. Freddi, D. Chan, K. S. E. Cheah, and J. F. Bateman Misfolding of Collagen X Chains Harboring Schmid Metaphyseal Chondrodysplasia Mutations Results in Aberrant Disulfide Bond Formation, Intracellular Retention, and Activation of the Unfolded Protein Response J. Biol. Chem., April 22, 2005; 280(16): 15544 - 15552. [Abstract] [Full Text] [PDF]

				C.-j. Liu, L. Prazak, M. Fajardo, S. Yu, N. Tyagi, and P. E. Di Cesare Leukemia/Lymphoma-related Factor, a POZ Domain-containing Transcriptional Repressor, Interacts with Histone Deacetylase-1 and Inhibits Cartilage Oligomeric Matrix Protein Gene Expression and Chondrogenesis J. Biol. Chem., November 5, 2004; 279(45): 47081 - 47091. [Abstract] [Full Text] [PDF]

				R. Bjarnason, B. Andersson, H. S. Kim, B. Olsson, D. Swolin-Eide, R. Wickelgren, B. Kristrom, B. Carlsson, K. Albertsson-Wikland, L. M. S. Carlsson, et al. Cartilage Oligomeric Matrix Protein Increases in Serum after the Start of Growth Hormone Treatment in Prepubertal Children J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5156 - 5160. [Abstract] [Full Text] [PDF]